What is AN2 Therapeutics Inc (ANTX) stock price today?

AN2 Therapeutics Inc (ANTX) currently trades at $4.68 per share. The stock has a market capitalization of $163.78M and a P/E ratio of —x.

Is ANTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, AN2 Therapeutics Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

ANTX

AN2 Therapeutics Inc

NASDAQ: ANTX · HEALTHCARE · BIOTECHNOLOGY

$4.68

-1.27% today

Updated 2026-04-29

Market cap

$163.78M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$1 – $7

Volume

1.7M

Market cap

$163.78M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$1 – $7

Volume

1.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$1.00

-78.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.24M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-41.47M	$-64.73M	$-51.32M	$-35.17M	$-8.71M
EPS	—	—	—	—	$-1.16
Free cash flow	$-33.46M	$-53.29M	$-49.26M	$-29.83M	$-5.24M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANTX	$163.78M	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

AN2 Therapeutics Inc trades at $4.68. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is AN2 Therapeutics Inc's stock price?

AN2 Therapeutics Inc (ANTX) trades at $4.68.

Is AN2 Therapeutics Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of AN2 Therapeutics Inc (ANTX)?

The analyst target price is $1.00, representing -78.6% downside from the current price of $4.68.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-52.10%

Beta-1.32

50D MA$3.34

200D MA$1.70

Shares out0.04B

Float0.02B

Short ratio—

Avg volume1.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANTX vs LLY →ANTX vs JNJ →ANTX vs ABBV →Stock screener →